Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:1763-1768

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hop, C.
Right arrow Articles by Pannekoek, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hop, C.
Right arrow Articles by Pannekoek, H.
Related Collections
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Research
Right arrow Cell biology/structural biology
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:1763.)
© 2000 American Heart Association, Inc.


Vascular Biology

Assembly of Multimeric von Willebrand Factor Directs Sorting of P-Selectin

Caroline Hop; Andrea Guilliatt; Martina Daly; Hubert P. de Leeuw; Herm-Jan M. Brinkman; Ian R. Peake; Jan A. van Mourik; Hans Pannekoek

From the Department of Biochemistry (C.H., H.P), Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands; the Department of Medicine and Pharmacology (A.G., M.D., I.R.P.), Section of Molecular Genetics, University of Sheffield, Sheffield, UK; and the Department of Blood Coagulation (H.P.d.L., H.-J.M.B., J.A.v.M.), CLB, Sanquin Blood Supply Foundation, Amsterdam, Netherlands.

Correspondence to Dr H. Pannekoek, Academic Medical Center, Department of Biochemistry (K1-159), Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands. E-mail h.pannekoek{at}amc.uva.nl


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract—We designed a model system to study the role of von Willebrand factor (vWF) in the sorting of P-selectin and the biogenesis of Weibel-Palade body (WPB)–like organelles. For that purpose, a human epithelial cell line (T24) that synthesizes P-selectin mRNA, but which is devoid of vWF mRNA synthesis and storage organelles, was transfected with full-length vWF cDNA or a deletion mutant thereof. Stable transfectants of T24 with full-length vWF cDNA revealed the generation of WPB-like organelles as demonstrated by colocalization of vWF and P-selectin with double-labeling immunofluorescence. In contrast, T24 cells transfected with vWF delD’D3 cDNA, encoding a mutant that is unable to form vWF multimers, displayed only perinuclear vWF staining, whereas no indication was found for the presence of WPB-like organelles. The contents of the organelles in full-length vWF cDNA–transfected T24 cells were released on activation of the protein kinase C pathway, similar to the situation with genuine endothelial cells. The expression of vWF did not affect the biosynthesis of P-selectin, as deduced from the observation that untransfected and vWF cDNA–transfected T24 cells contained the same amount of P-selectin mRNA. We propose that the biosynthesis of multimeric vWF directs the generation of WPB-like organelles, as evidenced by the sequestering and anchoring of P-selectin into these storage granules.


Key Words: von Willebrand factor • P-selectin • Weibel-Palade bodies • protein sorting


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Multimeric von Willebrand factor (vWF) is an obligatory glycoprotein for the formation of a hemostatic plug. It connects the platelet to the subendothelium that is exposed on injury of the vessel wall. vWF is synthesized by megakaryocytes and vascular endothelial cells. Endothelial cells display 2 secretory routes for newly synthesized vWF, namely, a constitutive and a regulated pathway.1 Constitutively secreted vWF is rapidly transported in secretory vesicles toward the plasma membrane. This material consists of vWF dimers and low-molecular-weight multimers. Another portion of the newly synthesized vWF is encountered in specific storage organelles, denoted Weibel-Palade bodies (WPBs). These organelles fuse with the plasma membrane on activation of the protein kinase C signal transduction pathway, followed by release of their contents (regulated secretion).2 3 vWF routed by this pathway consists of high-molecular-weight multimers that are {approx}2 orders of magnitude more effective in mediating adhesion of platelets to the injured vessel wall than are vWF dimers or low-molecular-weight multimers.4

The WPBs are considered to be endothelial cell–specific, rod-shaped, electron-dense storage organelles.5 Apart from vWF multimers and the vWF propolypeptide,6 7 8 the WPB contains a number of other proteins, namely CD63, a transmembrane glycoprotein that is also present in lysosomal membranes of many cell types9 10 ; interleukin-811 ; tissue plasminogen activator12 ; and the transmembrane receptor P-selectin (also called GMP-140 or PADGEM).13 14 P-selectin acts as an "anchor" for the adhesion of leukocytes to endothelial cells. Before that action, the protein kinase C signal transduction pathway must be activated, leading to fusion of WPBs with the plasma membrane and exposure of P-selectin on the cell surface. After guiding the adhesion of leukocytes, which may ultimately transmigrate to the subendothelium to combat local inflammation,15 P-selectin is endocytosed and recycled to the membrane of WPBs. Under physiological conditions, vWF and P-selectin are synthesized in the same cell types (endothelial cells and megakaryocytes) and sorted to the same organelles (endothelial WPBs and platelet {alpha}-granules). However, under pathophysiological conditions, other cell types are found to express P-selectin. Notably, it has been reported that epithelial cells from breast carcinomas,16 from paranasal chronic sinusitis mucosa,17 and from glomerulonephritis biopsies18 express P-selectin. This property has been exploited in this study to develop a model system to assess the role of vWF in the sorting of P-selectin and the biogenesis of WPB-like organelles.

The requirements for routing vWF to the WPBs are subject to discussion. Initially, it was proposed that storage of vWF was operational only in cells harboring a regulated, secretory pathway and that the propolypeptide of vWF acted as a sorting signal to direct vWF multimers to the storage organelles.19 However, full-length vWF cDNA–transfected heterologous cells, which are not known to harbor a regulated secretory pathway, all synthesize and store multimeric vWF in WPB-like organelles.20 21 The ability of heterologous, transfected cells to generate these organelles was correlated with the formation of multimers, because nonmultimerizing vWF deletion mutants are not stored in these granules. Taking these reports together, we proposed that the generation of these organelles is not an exclusive property of endothelial cells but that the biogenesis is triggered by the synthesis and assembly of multimeric vWF.20 21 Direct evidence for this hypothesis would be provided if we could demonstrate that sorting of a WPB-resident protein occurs exclusively in the presence of vWF synthesis and assembly of multimers. As a WPB-resident protein, P-selectin was chosen on the basis of observations that several epithelial cells express this protein under pathophysiological conditions.16 17 18 Accordingly, we found that the epithelial cell–like human cell line T2422 expresses P-selectin mRNA (vide infra), and therefore, we used these cells to design a model system to address the hypothesis outlined above. These cells lack endogenous vWF mRNA and are devoid of storage granules. Transfection of T24 cells with full-length vWF cDNA revealed that multimeric vWF triggers the biogenesis and assembly of WPB-like storage organelles, as evidenced by the sorting of P-selectin into these granules.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Tissue Culture and Transfection
T24 cells22 (human bladder carcinoma cells; ECACC No. 85061107) were maintained in medium 199 supplemented with 2 mmol/L glutamine, 100 U/mL penicillin, 100 µg/mL streptomycin, 2.5 µg/mL Fungizone, and 10% (vol/vol) heat-inactivated fetal calf serum (Gibco Laboratories). T24 cells were stably transfected with plasmid pSVL-vWF containing full-length vWF cDNA.20 The pSVL vector carries neomycin resistance that allows for selection during 10 days in culture medium containing 400 µg/mL neomycin (G418); 36 clones were later chosen, of which 19 survived. These clones were screened by immunofluorescence with the use of a rabbit anti-human vWF polyclonal antibody. Eleven clones expressed vWF antigen, of which T24-vWF-10 and T24-vWF-12 were chosen for further analysis. Plasmid pSVL-vWF delD’D3 was used for transient transfection.18 The composition of these plasmids has been described previously.23 24

RNA Isolation and Northern Blotting
Total RNA of T24 cells and of stably vWF cDNA–transfected cells was isolated with TRIzol reagent according to the manufacturer’s instructions (Gibco BRL). Northern blotting of 10 µg of RNA was done as described.25 A 482-bp HindIII (position 2235)–BamHI (position 2717) vWF cDNA fragment (GenBank accession number X04385), radiolabeled with use of the random-primer DNA labeling system (Gibco BRL) and [{alpha}-32P]dATP, was used as a probe for DNA-RNA hybridization. Unincorporated radioactivity was discarded by Sephadex G-50 chromatography. After hybridization, radioactive probes were removed by incubating the blots twice for 20 minutes at 90°C in 0.1x SSC, 0.1% SDS, and 1% sodium pyrophosphate. Subsequently, the blots were reused for hybridization with a radiolabeled 478-bp XhoI (position 561)–NcoI (position 1039) cDNA fragment of P-selectin (GenBank No. U02297), and after stripping the blot by washing as indicated above, the blots were reused for hybridization with a radiolabeled 84-bp EcoRI (position 517)–SalI (position 601) cDNA fragment of glyceraldehyde-3-phosphate dehydrogenase (GAPDH; GenBank No. M17851) for calibration of the amount of RNA applied.

Immunofluorescence
Cells were grown until they reached confluence on gelatin-coated glass coverslips. Then the cells were washed twice with 10 mmol/L sodium phosphate (pH 7.4), 0.14 mol/L NaCl (PBS) and subsequently fixed for 10 minutes at room temperature with methanol. After fixation, the cells were washed twice with PBS and incubated for 1 hour with 1 of the following: (1) a mixture of 3 murine anti-human vWF monoclonal antibodies (CLB-RAg 201, CLB-RAg 35, and CLB-RAg 21; all from CLB, Amsterdam, Netherlands); (2) a rabbit anti-human vWF polyclonal antibody (Dako-Patts, Glostrup, Denmark); (3) a rabbit anti-human cathepsin D polyclonal antiserum (kindly donated by Dr J.M.F.G. Aerts, Department of Biochemistry, Academic Medical Center, Amsterdam, Netherlands); (4) a mixture of 3 murine anti-human P-selectin monoclonal antibodies: F1.18 (a kind gift of Dr H.K. Nieuwenhuis, Academic Hospital Utrecht, Utrecht, Netherlands), C2 (a kind gift of Dr P. Modderman, CLB, Amsterdam, Netherlands), and CD62 (Pharmingen, San Diego, Calif); or (5) a combination of the antibodies listed above in PBS supplemented with 3% (Organon Teknika). Subsequently, the coverslips were washed twice with PBS and incubated for 1 hour with a cy-3 (Amersham/Pharmacia Biotech)–labeled conjugate of goat anti-mouse or goat anti-rabbit immunoglobulins, FITC-conjugated goat anti-mouse or goat anti-rabbit immunoglobulins (Jackson Immuno Research Laboratory), or both in PBS supplemented with 3% BSA and 0.1% (vol/vol) Tween-20. Finally, the coverslips were washed 3 times, prepared for microscopy by embedding in mounting medium, and analyzed under a fluorescence microscope (Axioplan 2, Zeiss). For single- and double-labeling experiments, the appropriate filters were used to visualize exclusively cy-3–labeled antigens (red) or FITC-labeled antigens (green).

Determination of vWF Antigen
The release of vWF antigen in the conditioned medium of cultured T24-vWF cells by secretagogues was measured by ELISA essentially as described previously.26


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Design of a Model System to Study Sorting of P-Selectin
It has been reported that neoplastic epithelial cells may express nonepithelial markers, such as the endothelial cell–specific protein P-selectin.16 Accordingly, we show here by Northern blotting analysis that human T24 carcinoma cells, which display an epithelial cell–like morphology,22 synthesize P-selectin mRNA but do not produce vWF mRNA, another endothelial cell marker (Figure 1ADown, lane 3). However, vWF mRNA synthesis was readily achieved by stable transfection with full-length vWF cDNA (Figure 1ADown, lanes 1 and 2). Northern blot analysis of RNA preparations of 2 independent clones, T24-vWF-10 and T24-vWF-12, revealed comparable amounts of vWF mRNA, as determined by PhosphorImager analysis, by using GAPDH mRNA as a standard for equal loading (Figure 1BDown). It should be noted that P-selectin mRNA synthesis is not affected by vWF expression, because synthesis of the former is similar in transfected and untransfected cells (Figure 1BDown). Transfected T24 cells were further explored as a model system to study vWF-directed sorting of P-selectin. To that end, we analyzed the fate of vWF and P-selectin proteins in these transfected cells.



View larger version (27K):
[in this window]
[in a new window]
 
Figure 1. Northern blot of T24 RNA and T24-vWF RNA probed with vWF cDNA, P-selectin cDNA, and GAPDH cDNA. The cells were cultured until confluent in 25-cm2 flasks, and total RNA was isolated. RNA (10 µg) was loaded onto a 0.8% agarose-formaldehyde gel and transferred to a Hybond N filter. Top, The blot was hybridized with radiolabeled vWF cDNA, P-selectin cDNA, and GAPDH cDNA probes as described in Methods, followed by autoradiography. Lanes 1, RNA from transfected T24-vWF-10 cells; lanes 2, RNA from transfected T24-vWF-12 cells; lanes 3, RNA from untransfected T24 cells. Bottom, Quantification of Northern blots by PhosphorImager. The mean values of 3 experiments are presented. Individual values for vWF mRNA, corrected for equal loading, differ by {approx}2%, whereas individual corrected values for P-selectin deviate by {approx}5%. The sizes of the respective mRNAs (nucleotides) are indicated.

Immunofluorescence Analysis of vWF cDNA–Transfected T24 Cells
Double-labeling immunofluorescence with both anti–P-selectin antibodies and anti-vWF polyclonal antibodies was performed to establish the presence and localization of vWF and P-selectin antigens. Nontransfected T24 cells showed no staining with anti-vWF polyclonal antibodies (Figure 2aDown). A homogeneous, faint background staining was consistently observed with anti–P-selectin antibodies in nontransfected T24 cells, indicative of cytoplasmic P-selectin (Figure 2dDown). Interestingly, stably transfected T24-vWF cells displayed a punctate staining pattern that was identical regardless of whether or not anti-vWF antibodies or anti–P-selectin antibodies were used (Figures 2bDown and 2eDown). Besides these punctate entities, it is noteworthy that no intracellular background staining was observed in T24-vWF cells with either 1 of these antibody preparations, in contrast to what was observed in untransfected cells with anti–P-selectin antibodies.



View larger version (139K):
[in this window]
[in a new window]
 
Figure 2. Double-labeling immunofluorescence analysis of T24 and T24-vWF cells with anti–P-selectin and anti-vWF antibodies. Cells were cultured on gelatin-coated coverslips for 4 to 7 days. After methanol fixation, the cells were incubated with monoclonal anti–P-selectin and polyclonal anti-vWF antibodies, followed by incubation with cy-3–conjugated goat anti-mouse and FITC-conjugated goat anti-rabbit immunoglobulins. a through c, Visualization of cy-3–labeled vWF antigen. d through f, Visualization of FITC-labeled P-selectin antigen. a and d, T24 cells; b and e, T24-vWF cells; c and f, T24-vWFdelD’D3 cells. Magnification used for all panels was x1000.

T24 cells were also transfected with plasmid pSVL-vWF delD’D3. This plasmid encodes a deletion mutant of vWF that is able to dimerize but is unable to multimerize owing to the lack of the D’ and D3 domains of vWF.23 As shown before, the absence of multimerization coincided with the lack of WPB-like vWF storage organelles in several different transfected cell types.21 23 Double labeling of T24-vWF delD’D3 cells with both anti-vWF and anti–P-selectin antibodies revealed a perinuclear vWF staining, representing the presence of vWF in the rough endoplasmic reticulum and in the Golgi apparatus (Figure 2cUp). However, with the anti–P-selectin antibodies, only faint cytoplasmic staining was observed in T24-vWF delD’D3 cells, similar to that seen in untransfected T24 cells (Figure 2fUp). Taking all of these observations into consideration, we concluded that the expression of full-length vWF cDNA leads to the formation of multimers, irrespective of the transfected cell type studied,19 20 23 24 and directs the biogenesis of organelles as visualized by a characteristic punctate staining pattern. Moreover, expression of multimeric vWF causes sequestering of P-selectin into these punctate entities, tentatively denoted as storage organelles.

Release of Stored Proteins by Activation of the Protein Kinase C Pathway
We verified whether the typical feature of WPBs of endothelial cells to release their contents on activation of the protein kinase C signal transduction pathway could also be attributed to the granules in transfected T24-vWF cells. For that purpose, T24-vWF cells were incubated for 1 hour with 2x10-6 mol/L phorbol dibutyrate (PDB), subsequently washed to remove the PDB, and allowed to recover for 24 hours. This agonist was chosen because of its property to be removed during washing of the cells, in contrast to the more frequently used phorbol myristate acetate (PMA). The cells were analyzed by immunofluorescence before activation, at 1 hour after activation, and after a recovery period of 24 hours (Figures 3aDown through 3c). Alternatively, cells were incubated for 1 hour with 1x10-7 mol/L of the potent agonist PMA dissolved in 0.1% (vol/vol) DMSO or with 0.1% (vol/vol) DMSO alone and processed as indicated above. In this case, PMA was chosen because it is considered a more potent agonist than PDB. The vWF released from activated T24-vWF cells and recovered from the conditioned medium was determined by ELISA. The conditioned medium of cells treated for 1 hour with 0.1% (vol/vol) DMSO alone contained 0.34±0.03 mU vWF per 1.5 mL, whereas cells activated for 1 hour with 1x10-7 mol/L PMA in DMSO contained 0.89±0.19 mU vWF per 1.5 mL of conditioned medium. These data and the immunofluorescence observations are consistent with the interpretation that the organelles of T24-vWF cells share essential features with genuine endothelial cell WPBs. Notably, the punctate vWF pattern initially disappeared on PDB (Figure 3bDown) or PMA treatment (concomitant with the appearance of vWF in the conditioned medium) and reappeared after an adequate recovery period (Figure 3cDown). Furthermore, it is worth mentioning that we attempted to observe the appearance of P-selectin at the surface of T24-vWF cells after PDB treatment but failed to detect P-selectin antigen by immunofluorescence analysis (see Methods), possibly owing to its transient exposure and rapid internalization (data not shown).



View larger version (27K):
[in this window]
[in a new window]
 
Figure 3. Immunofluorescence analysis of T24-vWF cells on activation of the protein kinase C pathway. Cells were cultured for 4 to 7 days on gelatin-coated coverslips. Then they were treated for 1 hour with 2x10-6 mol/L PDB. After extensive washing, the cells were cultured for another 24 hours. The cells were fixed by methanol and incubated with anti-vWF monoclonal antibodies, followed by incubation with cy-3–conjugated goat anti-mouse immunoglobulins. a, Without PDB; b, after 1-hour stimulation with PDB; and c, 24 hours after PDB treatment.

To exclude the possibility that the observed storage organelles in T24-vWF cells were lysosomal structures, double-labeling immunofluorescence was performed with a mixture of murine anti-human vWF monoclonal antibodies and a rabbit anti-human cathepsin D polyclonal antiserum. This experiment unambiguously showed that the intracellular localization of the typical lysosomal marker cathepsin D was distinct from that of vWF (Figure 4Down).



View larger version (201K):
[in this window]
[in a new window]
 
Figure 4. Immunofluorescence analysis of the WPBs of transfected T24-vWF cells by double labeling with anti-vWF and anti–cathepsin D antibodies. Cells were cultured on gelatin-coated coverslips for 4 to 7 days. After methanol fixation, the cells were incubated with anti-vWF monoclonal and anti–cathepsin D polyclonal antibodies, followed by incubation with cy-3–conjugated goat anti-rabbit and FITC-conjugated goat anti-mouse immunoglobulins. vWF is shown in green, cathepsin D in red. Magnification x630.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
The routing of P-selectin has been studied in several transfected cell types. These studies were performed in the absence of vWF synthesis.27 Specifically, murine pituitary AtT-20 cells, which have a regulated sorting pathway, and nonregulated Chinese hamster ovary cells were transfected with P-selectin cDNA. In P-selectin cDNA–transfected AtT-20 cells, P-selectin is routed to adrenocorticotropic hormone–containing storage granules, whereas in transfected Chinese hamster ovary cells, P-selectin is not stored but instead is exposed on the plasma membrane.27 From those observations and from the data reported in the current study, one may conclude that in the absence of vWF synthesis and multimeric assembly, P-selectin requires the presence of a regulated secretory pathway to be routed to storage granules. In the absence of both multimeric vWF assembly and a regulated secretory pathway, the fate of P-selectin is difficult to predict, because in P-selectin cDNA–transfected Chinese hamster ovary cells, the receptor is apparently exposed on the surface, whereas endogenously synthesized P-selectin in T24 cells is presumably present in the cytoplasm and not exposed on the surface, as deduced from the faint cytoplasmic staining of untransfected T24 cells (Figure 2dUp). However, it should be emphasized that under physiological conditions, the expression of P-selectin invariably occurs in the same cell types as that of vWF (ie, endothelial cells and megakaryocytes). Moreover, in both endothelial cells and megakaryocytes, P-selectin and vWF are routed and stored in the same compartment, and we speculate that cosorting of these proteins in the same cells is obligatorily linked.

In this study, we have provided further evidence for our proposal that the biogenesis of WPBs in endothelial cells or of WPB-like organelles in vWF cDNA–transfected heterologous cells is dependent on the synthesis and assembly of multimeric vWF.20 The major finding reported here is that the synthesis and assembly of multimeric vWF trigger sequestering of P-selectin into WPB-like storage organelles. In our view, these observations provide strong support for the hypothesis outlined before. Furthermore, our findings are reminiscent of the helper function of chromogranin B in the selective sorting of intermediates of a peptide hormone precursor.28 29 In those studies, it was demonstrated that overexpression of chromogranin B redirects these intermediates toward the regulated secretory pathway of AtT-20 cells. These observations can be explained by the tendency of chromogranin B to aggregate in the lumen of the trans-Golgi network, thereby enabling a selected set of proteins with a reduced aggregation capacity to be sorted to the same compartment of these neuroendocrine cells. Similarly, we propose that the aggregation (ie, multimerization) of vWF in the trans-Golgi network of endothelial cells or of heterologous vWF-transfected cells may have a helper function in sorting P-selectin, analogous to that of chromogranin B in the neuroendocrine cell line AtT-20. Finally, our findings on sequestering of P-selectin by multimeric vWF are also reminiscent of the data acquired by recent vWF and factor VIII coexpression studies in transfected AtT-20 cells and in bovine aortic endothelial cells.30 In both cell types, colocalization of factor VIII and vWF was observed in storage granules, whereas no storage of factor VIII could be detected in the absence of vWF synthesis. In those studies, it was elegantly shown that intracellular vWF–mediated trafficking of factor VIII was due to actual binding of factor VIII to vWF in the trans-Golgi network. Whether P-selectin also binds to multimeric vWF before assembly into storage granules remains to be established.

We speculate that the sequestering of P-selectin by multimeric vWF will have consequences for the pathology of atherosclerosis, as deduced from data obtained with experimental animals. First, studies with P-selectin–knockout mice have demonstrated that leukocyte rolling and extravasation are severely compromised compared with those processes in wild-type mice,31 providing support for an essential function of this receptor in early leukocyte recruitment at sites of inflammation. In this respect, it might be expected that the absence of P-selectin would protect against atherosclerosis.15 Indeed, this expectation has been borne out by the results of studies on the initiation and progression of atherosclerosis in P-selectin–knockout mice compared with wild-type mice, which were eventually crossed into an atherogenic apoE-knockout genetic background.32 33 Clearly, the absence of P-selectin protected against atherosclerosis, presumably by delaying the formation of fatty streaks. Second, it has been reported that pigs with von Willebrand disease, similar to human type 3 von Willebrand disease (ie, no vWF antigen), are relatively protected against diet-induced atherosclerosis.34 35 This finding has been attributed to the lack of vWF-mediated platelet adhesion to the subendothelium as an important contributing event to atherogenesis. In view of the findings on the sequestering and subsequent storage of P-selectin by multimeric vWF, we suggest that the protection from atherosclerosis in vWF-deficient pigs may be accounted for by the absence of vWF and the subsequent deficient availability of P-selectin.


*    Acknowledgments
 
This work was supported by the Netherlands Heart Foundation (grant 91.126).


*    Footnotes
 
Part of this work has been presented at the XVth Congress of the International Society on Thrombosis and Haemostasis, July 1997, Florence, Italy.

Received September 17, 1999; accepted January 18, 2000.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 

  1. Wagner DD. Cell biology of von Willebrand factor. Annu Rev Cell Biol. 1990;6:217–246.
  2. Loesberg C, Gonsalves MD, Zandbergen J, Willems C, van Aken WG, Stel HV, van Mourik JA, de Groot PhG. The effect of calcium on the secretion of factor VIII-related antigen by cultured endothelial cells. Biochim Biophys Acta. 1983;63:160–168.
  3. Hamilton KK, Sims PJ. Changes in cytosolic Ca2+ associated with von Willebrand factor release in human endothelial cells exposed to histamine. J Clin Invest. 1987;79:600–608.
  4. Federici AB, Bader R, Coliberti ML, de Marco L, Mannucci PM. Binding of von Willebrand factor to glycoproteins Ib and IIb/IIIa complex: affinity is related to multimer size. Br J Haematol. 1989;73:93–99.[Medline] [Order article via Infotrieve]
  5. Weibel ER, Palade GE. New cytoplasmic components in arterial endothelia. J Cell Biol. 1964;23:101–112.[Abstract/Free Full Text]
  6. Wagner DD, Olmsted JB, Marder VJ. Immunolocalization of von Willebrand protein in Weibel Palade bodies of human endothelial cells. J Cell Biol. 1982;95:355–360.[Abstract/Free Full Text]
  7. McCarrol DR, Levin EG, Montgomery RR. Endothelial cell synthesis of von Willebrand antigen-II, von Willebrand factor and von Willebrand factor/von Willebrand antigen II complex. J Clin Invest. 1985;75:1089–1095.
  8. Ewenstein BM, Warhol MJ, Handin RI, Pober JS. Composition of von Willebrand factor storage organelle (Weibel-Palade body) cultured from umbilical vein endothelial cells. J Cell Biol. 1987;104:1423–1433.[Abstract/Free Full Text]
  9. Metzelaar MJ, Wijngaard PLJ, Peters PJ, Sixma JJ, Nieuwenhuis HK, Clevers HC. CD63 antigen: a novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem. 1991;266:3239–3245.[Abstract/Free Full Text]
  10. Vischer UM, Wagner DD. CD63 is a component of Weibel-Palade bodies of human endothelial cells. Blood. 1993;82:1184–1190.[Abstract/Free Full Text]
  11. Wolff B, Burns AR, Middleton J, Rot A. Endothelial cell ‘memory’ of inflammatory stimulation: human venular endothelial cells store interleukin 8 in Weibel-Palade bodies. J Exp Med. 1998;188:1757–1762.[Abstract/Free Full Text]
  12. Rosnoblet C, Vischer UM, Gerard RD, Irminger JC, Halban PA, Kruithof EKO. Storage of tissue-type plasminogen activator in Weibel-Palade bodies of human endothelial cells. Arterioscler Thromb Vasc Biol. 1999;19:1796–1803.[Abstract/Free Full Text]
  13. Bonfanti R, Furie BC, Furie B, Wagner DD. PADGEM (GMP-140) is a component of Weibel Palade bodies of human endothelial cells. Blood. 1989;73:1109–1112.[Abstract/Free Full Text]
  14. McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. GMP-140, a platelet {alpha}-granule membrane protein, is also synthesized by vascular endothelial cells and is located in Weibel-Palade bodies. J Clin Invest. 1989;84:92–99.
  15. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801–809.[Medline] [Order article via Infotrieve]
  16. Fox SB, Turner GD, Gatter KC, Harris AL. The increased expression of adhesion molecules ICAM-3, E- and P-selectins on breast cancer endothelium. J Pathol. 1995;177:369–376.[Medline] [Order article via Infotrieve]
  17. Shimomura A, Ikeda K, Suzuki H, Nakabayashi S, Oshima T, Furukawa M, Takasaka T, Ando N, Ohtani H, Nagura H. Expression of adhesion molecules in nonallergic chronic sinusitis. Laryngoscope. 1997;107:1519–1524.[Medline] [Order article via Infotrieve]
  18. Li X, Zhou T, Hao C, Dong D, Cheng F, Chen S. Significance of P-selectin expression in human glomerulonephritis. Chin Med J. 1997;110:512–514.[Medline] [Order article via Infotrieve]
  19. Wagner DD, Saffaripour S, Bonfanti R, Sadler JW, Cramer EM, Chapman B, Mayadas TM. Induction of specific storage organelles by von Willebrand factor propolypeptide. Cell. 1991;46:403–413.
  20. Voorberg J, Fontijn R, Calafat J, Jansen H, van Mourik JA, Pannekoek H. Biogenesis of von Willebrand factor-containing organelles in heterologous transfected CV-1 cells. EMBO J. 1993;12:749–758.[Medline] [Order article via Infotrieve]
  21. Hop C, Fontijn R, van Mourik JA, Pannekoek H. Polarity of constitutive and regulated von Willebrand factor secreted by transfected MDCK-II cells. Exp. Cell Res. 1997;230:352–361.[Medline] [Order article via Infotrieve]
  22. Bubenik J, Baresova M, Viklicky V, Jakoubkova, J, Sainerova H, Donner J. Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen. Int J Cancer. 1973;11:765–773.[Medline] [Order article via Infotrieve]
  23. Voorberg J, Fontijn R, van Mourik JA, Pannekoek H. Domains involved in multimer assembly of von Willebrand factor (vWF): multimerization is independent of dimerization. EMBO J. 1990;9:797–803.[Medline] [Order article via Infotrieve]
  24. Voorberg J, Fontijn R, Calafat J, Jansen H, van Mourik JA, Pannekoek H. Assembly and routing of von Willebrand factor variants: the requirements for disulfide-linked dimerization reside within the carboxyl-terminal 151 amino acids. J Cell Biol. 1991;113:195–205.[Abstract/Free Full Text]
  25. Maniatis T, Fritsch EF, Sambrook J. In: Molecular Cloning: A Laboratory Handbook. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989.
  26. Borchiellini A, Fijnvandraat K, ten Cate JW, Pajkrt D, van Deventer SJH, Pasterkamp G, Meijer-Huizinga F, Zwart-Huinink L, Voorberg J, van Mourik JA. Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans. Blood. 1996;88:2951–2958.[Abstract/Free Full Text]
  27. Koedam JA, Cramer EM, Briend E, Furie B, Furie BC, Wagner DD. P-selectin, a granule membrane protein of platelets and endothelial cells, follows the regulated pathway in AtT-20 cells. J Cell Biol. 1992;116:617–625.[Abstract/Free Full Text]
  28. Natori S, Huttner WB. Chromogranin B (secretogranin I) promotes sorting to the regulated secretory pathway of processing intermediates derived from a peptide hormone precursor. Proc Natl Acad Sci U S A. 1996;93:4431–4436.[Abstract/Free Full Text]
  29. Glombik MM, Krömer A, Salm T, Huttner WB, Gerdes H-H. The disulfide-bonded loop of chromogranin B mediates membrane binding and directs sorting from the trans-Golgi network to secretory granules. EMBO J. 1999;18:1059–1070.[Medline] [Order article via Infotrieve]
  30. Rosenberg JB, Foster PA, Kaufman RJ. Vokac EA, Moussali M, Kroner PA, Montgomery RR. Intracellular trafficking of factor VIII to von Willebrand factor storage granules. J Clin Invest. 1998;101:613–624.[Medline] [Order article via Infotrieve]
  31. Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD. Leucocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell. 1993;74:541–554.[Medline] [Order article via Infotrieve]
  32. Johnson RC, Chapman SM, Dong ZM, Ordovas JM, Mayadas TN, Herz J, Hynes RO, Wagner DD. Absence of P-selectin delays fatty streak formation in mice. J Clin Invest. 1997;99:1037–1043.[Medline] [Order article via Infotrieve]
  33. Nageh MF, Sandbergh ET, Marotti KR, Lin AH, Melchior EP, Bullard DC, Beaudet AL. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 1997;17:1517–1520.[Abstract/Free Full Text]
  34. Fuster V, Bowie EJW, Lewis JC, Fass DN, Owen CA Jr, Brown AL. Resistance to arteriosclerosis in pigs with von Willebrand’s disease. J Clin Invest. 1978;61:722–730.
  35. Nichols TC, Belinger DA, Tate DA, Reddick RL, Read MS, Koch GG, Brinkhous KM, Griggs TR. Von Willebrand factor and occlusive arterial thrombosis: study in normal and von Willebrand’s disease pigs with diet-induced hypercholesterolemia and atherosclerosis. Arteriosclerosis. 1990;10:449–461.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
BloodHome page
S. L. Haberichter, E. P. Merricks, S. A. Fahs, P. A. Christopherson, T. C. Nichols, and R. R. Montgomery
Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells
Blood, January 1, 2005; 105(1): 145 - 152.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. G. Rondaij, E. Sellink, K. A. Gijzen, J. P. ten Klooster, P. L. Hordijk, J. A. van Mourik, and J. Voorberg
Small GTP-Binding Protein Ral Is Involved in cAMP-Mediated Release of von Willebrand Factor From Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., July 1, 2004; 24(7): 1315 - 1320.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
U. Fiedler, M. Scharpfenecker, S. Koidl, A. Hegen, V. Grunow, J. M. Schmidt, W. Kriz, G. Thurston, and H. G. Augustin
The Tie-2 ligand Angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies
Blood, June 1, 2004; 103(11): 4150 - 4156.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. S. Frenette
P-selectin and VWF tie the knot
Blood, March 15, 2004; 103(6): 1979 - 1980.
[Full Text] [PDF]


Home page
BloodHome page
S. L. Haberichter, P. Jacobi, and R. R. Montgomery
Critical independent regions in the VWF propeptide and mature VWF that enable normal VWF storage
Blood, February 15, 2003; 101(4): 1384 - 1391.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. B. Rosenberg, S. L. Haberichter, M. A. Jozwiak, E. A. Vokac, P. A. Kroner, S. A. Fahs, Y. Kawai, and R. R. Montgomery
The role of the D1 domain of the von Willebrand factor propeptide in multimerization of VWF
Blood, August 13, 2002; 100(5): 1699 - 1706.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. L. Haberichter, M. A. Jozwiak, J. B. Rosenberg, P. A. Christopherson, and R. R. Montgomery
The Von Willebrand Factor Propeptide (VWFpp) Traffics an Unrelated Protein to Storage
Arterioscler. Thromb. Vasc. Biol., June 1, 2002; 22(6): 921 - 926.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. D. Blagoveshchenskaya, M. J. Hannah, S. Allen, and D. F. Cutler
Selective and Signal-dependent Recruitment of Membrane Proteins to Secretory Granules Formed by Heterologously Expressed von Willebrand Factor
Mol. Biol. Cell, May 1, 2002; 13(5): 1582 - 1593.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. V. Denis, P. André, S. Saffaripour, and D. D. Wagner
Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice
PNAS, March 1, 2001; (2001) 61307098.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. V. Denis, P. Andre, S. Saffaripour, and D. D. Wagner
Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice
PNAS, March 27, 2001; 98(7): 4072 - 4077.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hop, C.
Right arrow Articles by Pannekoek, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hop, C.
Right arrow Articles by Pannekoek, H.
Related Collections
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Research
Right arrow Cell biology/structural biology